A History of the Concept of Atypical Depression
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Atypical depression is defined as a type of depression that responds preferentially to monoamine oxidase inhibitors. In addition to mood reactivity, symptoms of atypical depression include hypersomnia, hyperphagia or weight gain, leaden paralysis, and a long-standing pattern of rejection sensitivity or interpersonal sensitivity. Over the years, atypical depression has been associated with or identified as nonendogenous depression, anxiety, reverse vegetative shift, chronic pain, bipolar disorder, and rejection sensitivity. This presentation discusses the history of the identification of atypical depression, starting with its initial identification in 1959, and describes the important studies of atypical depression and its treatment by various research groups during the past 50 years. The presentation concludes by differentiating between typical and atypical depression and detailing of some of the clinical characteristics of atypical depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large European study, it was found that only one fifth of anxiety patients sought help from healthcare services, and of these, one fifth received no treatment (Alonso et al. 2007).”
From World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders (2023) · cites this paper as Alonso et al. 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Drug Treatment of Psychiatric Disorders
Klein, D. F. (1970) · The British Journal of Psychiatry · doi:10.1192/s0007125000193523 · Cited by 563
Diagnosis and drug treatment of psychiatric disorders : adults and children
Klein, D. F. (1980) · Williams & Wilkins eBooks · Cited by 417
Effects of Iproniazid in Depressive Syndromes
West, E. D., & Dally, P. J. (1959) · BMJ · doi:10.1136/bmj.1.5136.1491 · Cited by 382
Tranylcypromine versus imipramine in anergic bipolar depression
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.910 · Cited by 360 · cited 2×
“Subsequently, Himmelhoch et al.9 examined the efficacy of the MAOI tranylcypromine versus imipramine for the acute treatment (first 6 weeks) and continuation treatment (next 10 weeks) of patients with bipolar depression with reversed vegetative features.”
BackgroundSelf-citationAntidepressant Specificity in Atypical Depression
Liebowitz, M. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260037004 · Cited by 348 · cited 2×
“In 1988, Liebowitz et al.(24) reported on a 6-week, double-blind, randomized study of imipramine, phenelzine, and placebo in 119 patients who met the Columbia criteria for atypical depression.”
BackgroundKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050025004 · Cited by 323
The high prevalence of “Soft” bipolar (II) features in atypical depression
Perugi, G., Akiskal, H. S., Lattanzi, L., Cecconi, D., Mastrocinque, C., Patronelli, A., Vignoli, S., & Bemi, E. (1998) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(98)90080-3 · Cited by 304
Atypical Facial Pain and Depression
Lascelles, R. G. (1966) · British Journal of Psychiatry · doi:10.1192/bjp.112.488.651 · Cited by 217
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.3.306 · Cited by 198 · cited 2×
“At the same time, Quitkin et al.(25) demonstrated the superiority of phenelzine over placebo and imipramine in a group of patients with probable atypical depression, i.”
BackgroundHypersomnia and Manic-Depressive Disease
DETRE, T., HIMMELHOCH, J., SWARTZBURG, M., ANDERSON, C. M., BYCK, R., & KUPFER, D. J. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.128.10.1303 · Cited by 170 · cited 2×
“In a small (N = 84) questionnaire-based study, Detre et al.(8)”
Background
Research works printed but not linked: 8
- Pollitt J, Young J. Anxiety state or masked depression? a study based on the action of monoamine oxidase inhibitors. Br J Psychiatry 1971;119: 143-149
- Raft D, Davidson J, Mattox A, et al. Double-blind evaluation of phenelzine, amitriptyline and placebo in depression associated with pain. In: Singer A, ed. Monoamine Oxidase: Structure, Function and Altered Functions. New York, NY: Academic Press; 1979:507-516
- Robinson DS, Nies A, Ravaris CL, et al. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states: a controlled clinical trial. Arch Gen Psychiatry 1973;29:407-413
- Quitkin FM, McGrath PJ, Stewart JW, et al. Atypical depression, panic J Clin Psychiatry 2007;68 (suppl 3) attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990;47:935-941
- Quitkin FM, Harrison W, Stewart JW, et al. Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Arch Gen Psychiatry 1991;48: 319-323
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
- Vaishnavi S, Gadde K, Alamy S, et al. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. J Clin Psychopharmacol 2006;26:373-378
- Matza LS, Revicki DA, Davidson JR, et al. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 2003;60:817-826
Cited by
Items 101–119 of 119
Tavor auf Palliativstation – wer wird ruhiggestellt?
Maier, B. O. (2017) · Leidfaden · doi:10.13109/leid.2017.6.3.40
Tavor auf Palliativstation – wer wird ruhiggestellt?
Maier, B. O. (2017) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666806193.40
Conclusions and future directions
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0011
The POP model of clinical reasoning: Description and implications
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0007
The role of model construction in developing expertise in psychiatry
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0009
Changing goals and changing models: The case of Mr Z
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0004
Shifting and conflicting models: The case of Ms M
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0006
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.002.0002
Models and patient values: The case of Mr D
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0005
Does evidence-based medicine provide a clinical method?
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0002
Introduction: The need to articulate a method of clinical reasoning in psychiatry
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0001
The role of models in clinical reasoning
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0003
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.002.0006
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.002.0007
How Psychiatrists Make Decisions: The Science of Clinical Reasoning
Heinrichs, D. W. (2025) · doi:10.1093/9780198960720.001.0001 · Cited by 1
Justifying knowledge claims in psychiatric reasoning
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0010
How we reason and make decisions
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.003.0008
Heinrichs, D. W. (2025) · Oxford University Press eBooks · doi:10.1093/9780198960720.002.0005
Raitiere, M. N. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1838966
“…et al., 1984), hypersomnia in the psychiatric literature often figures as a symptom, one that has caused the depressive phase of SAD/BD to be classified within a nosological category that originated independently of seasonal interests, namely “atypical depression” (Davidson and Thase, 2007).”
Metadata
- Authors
- Davidson, J. R. T., & Thase, M. E.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Davidson, Jonathan R. T.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-02-15
- Volume
- 68
- Issue
- 02
- Pages
- e03
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2166644681
- Cited by
- 119
- References
- 30
- Citations by year
- 2026: 3 · 2025: 19 · 2023: 2 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 10 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- atypical depression, monoamine oxidase inhibitors, mood reactivity, hypersomnia, hyperphagia, rejection sensitivity, chronic pain, bipolar disorder
- MeSH terms
- Clinical Trials as Topic, Depressive Disorder, Humans, Monoamine Oxidase Inhibitors, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.